Sigyn Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2015 to Q3 2024.
  • Sigyn Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.27M shares, a 14.7% increase year-over-year.
  • Sigyn Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.1M shares, a 17.7% increase from 2022.
  • Sigyn Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 935K shares, a 97.4% decline from 2021.
  • Sigyn Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 36.4M shares, a 395% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.27M +163K +14.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 1.24M +155K +14.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 1.23M +269K +27.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.1M +165K +17.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 1.11M -36.2M -97% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 1.08M -36.2M -97.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 962K -36.3M -97.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 935K -35.5M -97.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 37.3M +574K +1.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 37.3M +885K +2.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 37.3M +2.03M +5.75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 36.4M +29M +395% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 36.7M +36.2M +7244% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 36.4M +35.9M +7182% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 35.3M +34.8M +6953% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 7.35M +6.85M +1370% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 500K -41.8K -7.72% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 500K -80.8M -99.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 500K -80.8M -99.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 500K -64.6M -99.2% Oct 29, 2019 Dec 31, 2019 10-K 2021-04-06
Q3 2019 542K -64.9M -99.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 81.3M +19.4M +31.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 81.3M +23.6M +40.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 65.1M +18M +38.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 65.5M +17.4M +36.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 61.9M +17.5M +39.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 57.7M +14M +32% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-19
Q4 2017 47.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 48M +13.6M +39.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 44.3M +9.93M +28.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 43.7M +9.38M +27.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 34.4M +2.68M +8.44% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q2 2016 34.4M +4.2M +13.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 34.3M +4.34M +14.5% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 31M Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 31.7M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 30.2M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 30M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.